(Q28586417)

31 January 2017

title

BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells (English)

1 reference

POU domain, class 3, transcription factor 2

31 January 2017

main subject

1 reference

GOA release 2020-03-11

4

Anja K. Bosserhoff

1 reference

31 January 2017

3

Therese J. Resink

1 reference

31 January 2017

2

Manjunath B. Joshi

1 reference

31 January 2017

Lisa Ellmann

1

1 reference

31 January 2017

Silke Kuphal

series ordinal

5

1 reference

31 January 2017

publication date

1 December 2012

1 reference

31 January 2017

published in

Laboratory Investigation

1 reference

31 January 2017

volume

92

1 reference

31 January 2017

issue

12

1 reference

31 January 2017

page(s)

1788–1800

1 reference

The H-cadherin (CDH13) gene is inactivated in human lung cancer

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

The Brn-2 transcription factor links activated BRAF to melanoma proliferation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

The virtuoso of versatility: POU proteins that flex to fit

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

Functional role of MIA in melanocytes and early development of melanoma

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

Aryl hydrocarbon receptor ligands repress T-cadherin expression in vascular smooth muscle cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

The role of Kit-ligand in melanocyte development and epidermal homeostasis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2012.140

Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

H-cadherin expression reduces invasion of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Normal human melanocyte homeostasis as a paradigm for understanding melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Brn-2 Represses Microphthalmia-Associated Transcription Factor Expression and Marks a Distinct Subpopulation of Microphthalmia-Associated Transcription Factor-Negative Melanoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

A requirement for thioredoxin in redox-sensitive modulation of T-cadherin expression in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Tissue microarrays for miniaturized high-throughput molecular profiling of tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Epigenetic versus genetic alterations in the inactivation of E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Transcriptional regulation of cadherins during development and carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Characteristics of smooth muscle cell lipoprotein binding proteins (p105/p130) as T-cadherin and regulation by positive and negative growth regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Regulation of T-cadherin by hormones, glucocorticoid and EGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Lineage-specific transcriptional regulation of DICER by MITF in melanocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

KIT as a therapeutic target in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.140

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2012.140

1 reference

Dimensions Publication ID

31 January 2017

1020019457

0 references

1 reference